BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pacheco Y, Barahona-Correa J, Monsalve DM, Acosta-Ampudia Y, Rojas M, Rodríguez Y, Saavedra J, Rodríguez-Jiménez M, Mantilla RD, Ramírez-Santana C, Molano-González N, Anaya JM. Cytokine and autoantibody clusters interaction in systemic lupus erythematosus. J Transl Med 2017;15:239. [PMID: 29178890 DOI: 10.1186/s12967-017-1345-y] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 5.4] [Reference Citation Analysis]
Number Citing Articles
1 Ramkissoon CM, Güemes A, Vehi J. Overview of therapeutic applications of non-invasive vagus nerve stimulation: a motivation for novel treatments for systemic lupus erythematosus. Bioelectron Med 2021;7:8. [PMID: 34030736 DOI: 10.1186/s42234-021-00069-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Xu WD, Huang AF. Comment on: Interleukin-32γ: Possible association with the activity and development of nephritis in patients with systemic lupus erythematosus. Int J Rheum Dis 2019;22:1344-5. [PMID: 31328404 DOI: 10.1111/1756-185X.13608] [Reference Citation Analysis]
3 Rojas M, Ramírez-Santana C, Acosta-Ampudia Y, Monsalve DM, Rodriguez-Jimenez M, Zapata E, Naranjo-Pulido A, Suárez-Avellaneda A, Ríos-Serna LJ, Prieto C, Zambrano-Romero W, Valero MA, Rodríguez Y, Mantilla RD, Zhu C, Li QZ, Toro-Gutiérrez CE, Tobón GJ, Anaya JM. New insights into the taxonomy of autoimmune diseases based on polyautoimmunity. J Autoimmun 2022;126:102780. [PMID: 34923432 DOI: 10.1016/j.jaut.2021.102780] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Williams SG, Wolin SL. The Autoantigen Repertoire and the Microbial RNP World. Trends Mol Med 2021;27:422-35. [PMID: 33722441 DOI: 10.1016/j.molmed.2021.02.003] [Reference Citation Analysis]
5 Fernández Matilla M, Grau García E, Fernández-Llanio Comella N, Chalmeta Verdejo I, Ivorra Cortés J, Castellano Cuesta JA, Román Ivorra JA. Increased interferon-1α, interleukin-10 and BLyS concentrations as clinical activity biomarkers in systemic lupus erythematosus. Med Clin (Barc) 2019;153:225-31. [PMID: 30795903 DOI: 10.1016/j.medcli.2018.12.012] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Sag E, Demir S, Ozen S. Clusters in Pediatric Rheumatic Diseases. Curr Rheumatol Rep 2020;22:28. [PMID: 32436006 DOI: 10.1007/s11926-020-00908-5] [Reference Citation Analysis]
7 Acosta-Ampudia Y, Monsalve DM, Rojas M, Rodríguez Y, Gallo JE, Salazar-Uribe JC, Santander MJ, Cala MP, Zapata W, Zapata MI, Manrique R, Pardo-Oviedo JM, Camacho B, Ramírez-Santana C, Anaya JM; CP-COVID-19 group. COVID-19 convalescent plasma composition and immunological effects in severe patients. J Autoimmun 2021;118:102598. [PMID: 33524876 DOI: 10.1016/j.jaut.2021.102598] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 14.0] [Reference Citation Analysis]
8 Guthridge JM, Wagner CA, James JA. The promise of precision medicine in rheumatology. Nat Med 2022. [PMID: 35788174 DOI: 10.1038/s41591-022-01880-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Tan G, Baby B, Zhou Y, Wu T. Emerging Molecular Markers Towards Potential Diagnostic Panels for Lupus. Front Immunol 2021;12:808839. [PMID: 35095896 DOI: 10.3389/fimmu.2021.808839] [Reference Citation Analysis]
10 Zhou Z, You Y, Wang F, Sun Y, Teng J, Liu H, Cheng X, Su Y, Shi H, Hu Q, Chi H, Jia J, Wan L, Liu T, Wang M, Shi C, Yang C, Ye J. Urine Proteomics Differentiate Primary Thrombotic Antiphospholipid Syndrome From Obstetric Antiphospholipid Syndrome. Front Immunol 2021;12:702425. [PMID: 34489952 DOI: 10.3389/fimmu.2021.702425] [Reference Citation Analysis]
11 Meroni PL, Borghi MO. Diagnostic laboratory tests for systemic autoimmune rheumatic diseases: unmet needs towards harmonization. Clin Chem Lab Med 2018;56:1743-8. [PMID: 29708880 DOI: 10.1515/cclm-2018-0066] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
12 Ding J, Su S, You T, Xia T, Lin X, Chen Z, Zhang L. Serum interleukin-6 level is correlated with the disease activity of systemic lupus erythematosus: a meta-analysis. Clinics (Sao Paulo) 2020;75:e1801. [PMID: 33084768 DOI: 10.6061/clinics/2020/e1801] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
13 Reynolds JA, McCarthy EM, Haque S, Ngamjanyaporn P, Sergeant JC, Lee E, Lee E, Kilfeather SA, Parker B, Bruce IN. Cytokine profiling in active and quiescent SLE reveals distinct patient subpopulations. Arthritis Res Ther 2018;20:173. [PMID: 30092845 DOI: 10.1186/s13075-018-1666-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
14 Fritzler MJ, Mahler M. Redefining systemic lupus erythematosus - SMAARTT proteomics. Nat Rev Rheumatol 2018;14:451-2. [PMID: 29907860 DOI: 10.1038/s41584-018-0035-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
15 Park J, Jang W, Park HS, Park KH, Kwok SK, Park SH, Oh EJ. Cytokine clusters as potential diagnostic markers of disease activity and renal involvement in systemic lupus erythematosus. J Int Med Res 2020;48:300060520926882. [PMID: 32489126 DOI: 10.1177/0300060520926882] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Rojas M, Heuer LS, Zhang W, Chen Y, Ridgway WM. The long and winding road: From mouse linkage studies to a novel human therapeutic pathway in type 1 diabetes. Front Immunol 2022;13:918837. [DOI: 10.3389/fimmu.2022.918837] [Reference Citation Analysis]
17 Giemza-Stokłosa J, Islam MA, Kotyla PJ. Hyperferritinaemia: An Iron Sword of Autoimmunity. Curr Pharm Des 2019;25:2909-18. [PMID: 31686632 DOI: 10.2174/1381612825666190709202804] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
18 Mahler M. Lack of standardisation of ANA and implications for drug development and precision medicine. Ann Rheum Dis 2019;78:e33. [PMID: 29574414 DOI: 10.1136/annrheumdis-2018-213374] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
19 Torell F, Eketjäll S, Idborg H, Jakobsson P, Gunnarsson I, Svenungsson E, Trygg J. Cytokine Profiles in Autoantibody Defined Subgroups of Systemic Lupus Erythematosus. J Proteome Res 2019;18:1208-17. [DOI: 10.1021/acs.jproteome.8b00811] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
20 Barahona-Correa JE, Romero-Alvernia DM, Rueda-Ortiz C, Muñoz O, Garcia AA, Fernández-Ávila DG. Social media as source of information for Spanish-speaking patients with systemic lupus erythematosus. Lupus 2022;:9612033221098884. [PMID: 35549754 DOI: 10.1177/09612033221098884] [Reference Citation Analysis]
21 Anaya J, Leon KJ, Rojas M, Rodriguez Y, Pacheco Y, Acosta-ampudia Y, Monsalve DM, Ramirez-santana C. Progress towards precision medicine for lupus: the role of genetic biomarkers. Expert Review of Precision Medicine and Drug Development 2018;3:119-35. [DOI: 10.1080/23808993.2018.1448266] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
22 Ahn GY, Lee J, Won S, Ha E, Kim H, Nam B, Kim JS, Kang J, Kim JH, Song GG, Kim K, Bae SC. Identifying damage clusters in patients with systemic lupus erythematosus. Int J Rheum Dis 2020;23:84-91. [PMID: 31762221 DOI: 10.1111/1756-185X.13745] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Molano-González N, Rojas M, Monsalve DM, Pacheco Y, Acosta-Ampudia Y, Rodríguez Y, Rodríguez-Jimenez M, Ramírez-Santana C, Anaya JM. Cluster analysis of autoimmune rheumatic diseases based on autoantibodies. New insights for polyautoimmunity. J Autoimmun 2019;98:24-32. [PMID: 30459097 DOI: 10.1016/j.jaut.2018.11.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
24 Mao YM, Zhao CN, Liu LN, Wu Q, Dan YL, Wang DG, Pan HF. Increased circulating interleukin-8 levels in systemic lupus erythematosus patients: a meta-analysis. Biomark Med 2018;12:1291-302. [PMID: 30511585 DOI: 10.2217/bmm-2018-0217] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
25 Jung JH, Lim JH, Song GG, Kim BY. Association between interleukin 12B and interleukin 23R gene polymorphisms and systemic lupus erythematosus: a meta-analysis. J Int Med Res 2022;50:3000605221075220. [PMID: 35086377 DOI: 10.1177/03000605221075220] [Reference Citation Analysis]
26 Diaz-Gallo LM, Oke V, Lundström E, Elvin K, Ling Wu Y, Eketjäll S, Zickert A, Gustafsson JT, Jönsen A, Leonard D, Birmingham DJ, Nordmark G, Bengtsson AA, Rönnblom L, Gunnarsson I, Yu CY, Padyukov L, Svenungsson E. Four Systemic Lupus Erythematosus Subgroups, Defined by Autoantibodies Status, Differ Regarding HLA-DRB1 Genotype Associations and Immunological and Clinical Manifestations. ACR Open Rheumatol 2021. [PMID: 34658170 DOI: 10.1002/acr2.11343] [Reference Citation Analysis]
27 Guthridge JM, Lu R, Tran LT, Arriens C, Aberle T, Kamp S, Munroe ME, Dominguez N, Gross T, DeJager W, Macwana SR, Bourn RL, Apel S, Thanou A, Chen H, Chakravarty EF, Merrill JT, James JA. Adults with systemic lupus exhibit distinct molecular phenotypes in a cross-sectional study. EClinicalMedicine 2020;20:100291. [PMID: 32154507 DOI: 10.1016/j.eclinm.2020.100291] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
28 Bolouri N, Akhtari M, Farhadi E, Mansouri R, Faezi ST, Jamshidi A, Mahmoudi M. Role of the innate and adaptive immune responses in the pathogenesis of systemic lupus erythematosus. Inflamm Res 2022. [PMID: 35298669 DOI: 10.1007/s00011-022-01554-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
29 Sete MRC, Carlos JC, Lira-Junior R, Boström EA, Sztajnbok FR, Figueredo CM. Clinical, immunological and microbial gingival profile of juvenile systemic lupus erythematosus patients. Lupus 2019;28:189-98. [PMID: 30563424 DOI: 10.1177/0961203318819134] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
30 Monzavi SM, Alirezaei A, Shariati-Sarabi Z, Tavakol Afshari J, Mahmoudi M, Dormanesh B, Jahandoost F, Khoshdel AR, Etemad Rezaie A. Efficacy analysis of hydroxychloroquine therapy in systemic lupus erythematosus: a study on disease activity and immunological biomarkers. Inflammopharmacology 2018;26:1175-82. [PMID: 29987550 DOI: 10.1007/s10787-018-0512-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]